Warfarin use suboptimal in new-onset atrial fibrillation

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.427, 2003-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Barriers to warfarin use in atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1224, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

ACE inhibitors, ARBs prevent new-onset atrial fibrillation

By  

Inpharma, Vol. 1, Iss. 1550, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Predictors of Warfarin Use in Atrial Fibrillation Patients in the Inpatient Setting

By Agarwal Shuchita  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 37-48

Adis International

Access to resources Recommend Favorite

Intravenous vernakalant: a guide to its use in recent-onset atrial fibrillation

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 8, 2011-08 ,pp. : 6-10

Adis International

Access to resources Recommend Favorite

The Use of Drugs for Cardioversion of Recent Onset Atrial Fibrillation and Flutter: Focus on Ibutilide

By Obel O.A.   Camm A.J.  

Drugs & Aging, Vol. 12, Iss. 6, 1998-06 ,pp. : 461-476

Adis International

Access to resources Recommend Favorite